Table S1.

Characteristics of IBD patients whose tissue has been used for metabololipidomic analyses

CharacteristicCTRIBD
n (F/M)11 (5/6)10 (9/1)
Age median (y, range)75.0 (46–91)38.5 (24–66)
Severity of disease
 Score CDAI median (range)132.6 (12.6–324.8)
 Score CDEIS median (range)3.4 (1.5–12)
Treatments
 5-ASA7
 Azathioprine3
 Anti-TNF3
 Nontreated1
  • CDAI, Crohn’s Disease Activity Index; CDEIS, Crohn’s Disease Endoscopic Index of Severity; CTR, healthy controls; F, female; IBD, n = 10 ulcerative colitis and n = 2 Crohn’s disease); M, male; 5-ASA, 5-aminosalicylic acid.